+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomarkers Market by Biomarker Type, Technology, Application, End User, Biomarker Source - Global Forecast to 2030- Product Image
Biomarkers Market by Biomarker Type, Technology, Application, End User, Biomarker Source - Global Forecast to 2030- Product Image
Sale

Biomarkers Market by Biomarker Type, Technology, Application, End User, Biomarker Source - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082615
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biomarkers market is evolving rapidly, driven by advancements in diagnostics, drug development, and personalized healthcare strategies. Senior leaders must navigate complex, fragmented value chains while making evidence-based decisions amid global innovation and regulatory change.

Market Snapshot: Biomarkers Market Size, Growth & Opportunity

The Biomarkers Market grew from USD 59.69 billion in 2024 to USD 68.30 billion in 2025. It is expected to continue growing at a CAGR of 14.30%, reaching USD 133.17 billion by 2030. Market expansion is underscored by multidisciplinary innovation across diagnostics, therapeutic evaluation, and patient monitoring. Adoption accelerates as stakeholders across clinical laboratories, pharmaceutical firms, and research institutes leverage next-generation solutions for improved patient outcomes and operational efficiencies. Forward-looking companies are optimizing strategies to secure position in an increasingly competitive landscape.

Scope & Segmentation: Strategic Dimensions

This comprehensive report dissects the biomarkers market through multiple lenses, enabling detailed evaluation across core modalities, technologies, and end-user segments. Major segmentation elements include:

  • Biomarker Types: Cellular (flow cytometry, immunohistochemistry); Genetic (epigenetic, miRNA, SNPs); Imaging (CT, MRI, PET, ultrasound); Molecular (genomics—next generation sequencing, PCR; metabolomics—mass spectrometry, NMR spectroscopy; proteomics—mass spectrometry, protein microarray)
  • Technologies: Mass spectrometry (LC-MS, MALDI-TOF); Microarray (DNA, protein); PCR (digital, quantitative); Sequencing (next generation, Sanger)
  • Applications: Diagnostics (disease diagnosis—cardiology, neurology, oncology; prognostics; therapeutic monitoring); Drug development (biomarker discovery, clinical trials); Personalized medicine (companion diagnostics, pharmacogenomics); Research use (basic, translational)
  • End Users: Diagnostic laboratories; Hospitals and clinics (general, specialist); Pharmaceutical companies (big pharma, biotech); Research institutes (academic, government agencies)
  • Biomarker Sources: Blood (plasma, serum, whole blood); Saliva; Tissue (biopsy, tumor); Urine
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., QIAGEN N.V., Illumina, Inc., Siemens Healthineers AG

Key Takeaways for Decision-Makers

  • Biomarker technologies, spanning cellular, genetic, imaging, and molecular modalities, are central to advancements in precision medicine, informing patient stratification and therapy selection.
  • Integration of artificial intelligence and digital platforms is enhancing diagnostic workflows through automated data analysis and improved pattern recognition, supporting scalable innovation in clinical and research settings.
  • Collaborations between pharmaceutical companies and diagnostic developers are deepening, paving the way for companion diagnostics and more effective drug pipelines.
  • The decentralization of clinical trials and rise of point-of-care testing expand access, particularly in underserved regions, supporting equitable healthcare delivery.
  • Supply chain pressures, such as increased tariffs, are prompting greater geographic diversification and local manufacturing, building resilience but adding complexity around regulatory compliance.
  • Diverse regional priorities shape adoption: the Americas and Asia-Pacific lead in infrastructure and research investments, while Europe, the Middle East, and Africa increasingly focus on scalable, cost-effective biomarker platforms.

Tariff Impact: Market Effects and Strategic Response

U.S. tariff measures introduced in 2025 are impacting the biomarker supply chain by increasing costs for imported reagents and complex instruments. In response, companies are shifting production closer to end markets or sourcing alternative suppliers to cushion pricing volatility. Regional manufacturing initiatives, especially in North America, are addressing some challenges, but new hurdles in quality management and regulatory alignment arise as a result. Labs and organizations are also prioritizing technology platforms that allow flexible, multi-purpose use, reducing dependency on single-use, tariff-sensitive imports.

Methodology & Data Sources

This report combines extensive secondary research, public filings, and scientific literature with primary interviews involving laboratory leaders, regulatory experts, and research executives. Data triangulation processes and peer review ensure robust findings, while market segmentation is grounded in clearly defined criteria for biomarker type, technology, end user, and geography.

Why This Report Matters

  • Delivers executive-ready insights essential for informed investment and partnership strategies in the evolving biomarkers market.
  • Identifies actionable trends in regional procurement, supply chain management, and technology adoption, helping leaders mitigate operational risks.
  • Supports faster and more confident decision-making with rigorously validated, real-world industry intelligence.

Conclusion

This analysis enables stakeholders to deploy competitive strategies in a fast-changing biomarkers environment. Market evolution depends on agility, data-driven planning, and proactive engagement with regulatory and technology shifts.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biomarkers Market, by Biomarker Type
8.1. Introduction
8.2. Cellular
8.2.1. Flow Cytometry
8.2.2. Immunohistochemistry
8.3. Genetic
8.3.1. Epigenetic
8.3.2. Mirna
8.3.3. Snp
8.4. Imaging
8.4.1. Ct
8.4.2. Mri
8.4.3. Pet
8.4.4. Ultrasound
8.5. Molecular
8.5.1. Genomic
8.5.1.1. Next Generation Sequencing
8.5.1.2. Pcr
8.5.2. Metabolomic
8.5.2.1. Mass Spectrometry
8.5.2.2. Nmr Spectroscopy
8.5.3. Proteomic
8.5.3.1. Mass Spectrometry
8.5.3.2. Protein Microarray
9. Biomarkers Market, by Technology
9.1. Introduction
9.2. Mass Spectrometry
9.2.1. Lc Ms
9.2.2. Maldi Tof
9.3. Microarray
9.3.1. Dna Microarray
9.3.2. Protein Microarray
9.4. Pcr
9.4.1. Digital Pcr
9.4.2. Quantitative Pcr
9.5. Sequencing
9.5.1. Next Generation Sequencing
9.5.2. Sanger Sequencing
10. Biomarkers Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Disease Diagnosis
10.2.1.1. Cardiology
10.2.1.2. Neurology
10.2.1.3. Oncology
10.2.2. Prognostics
10.2.3. Therapeutic Monitoring
10.3. Drug Development
10.3.1. Biomarker Discovery
10.3.2. Clinical Trials
10.4. Personalized Medicine
10.4.1. Companion Diagnostics
10.4.2. Pharmacogenomics
10.5. Research Use
10.5.1. Basic Research
10.5.2. Translational Research
11. Biomarkers Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals And Clinics
11.3.1. General Hospitals
11.3.2. Specialist Clinics
11.4. Pharmaceutical Companies
11.4.1. Big Pharma
11.4.2. Biotech Firms
11.5. Research Institutes
11.5.1. Academic Institutions
11.5.2. Government Agencies
12. Biomarkers Market, by Biomarker Source
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.2.3. Whole Blood
12.3. Saliva
12.4. Tissue
12.4.1. Biopsy
12.4.2. Tumor Tissue
12.5. Urine
13. Americas Biomarkers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biomarkers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biomarkers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. F. Hoffmann-La Roche Ltd
16.3.3. Danaher Corporation
16.3.4. Abbott Laboratories
16.3.5. Agilent Technologies, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. QIAGEN N.V.
16.3.9. Illumina, Inc.
16.3.10. Siemens Healthineers AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOMARKERS MARKET MULTI-CURRENCY
FIGURE 2. BIOMARKERS MARKET MULTI-LANGUAGE
FIGURE 3. BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOMARKERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOMARKERS MARKET SIZE, BY EPIGENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMARKERS MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOMARKERS MARKET SIZE, BY SNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMARKERS MARKET SIZE, BY CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOMARKERS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMARKERS MARKET SIZE, BY PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOMARKERS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOMARKERS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMARKERS MARKET SIZE, BY GENOMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMARKERS MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEOMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOMARKERS MARKET SIZE, BY LC MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMARKERS MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMARKERS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOMARKERS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOMARKERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOMARKERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOMARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOMARKERS MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOMARKERS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOMARKERS MARKET SIZE, BY RESEARCH USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOMARKERS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOMARKERS MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOMARKERS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOMARKERS MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOMARKERS MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOMARKERS MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOMARKERS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOMARKERS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BIOMARKERS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BIOMARKERS MARKET SIZE, BY TUMOR TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 155. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 156. CANADA BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 157. CANADA BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 158. CANADA BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 159. CANADA BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 160. CANADA BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 161. CANADA BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 162. CANADA BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 163. CANADA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. CANADA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 165. CANADA BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 166. CANADA BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 167. CANADA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 168. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. CANADA BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 170. CANADA BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 171. CANADA BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 172. CANADA BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 173. CANADA BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 174. CANADA BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. CANADA BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 176. CANADA BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 177. CANADA BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 178. CANADA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 179. CANADA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 180. CANADA BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 181. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 182. MEXICO BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 183. MEXICO BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 184. MEXICO BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 185. MEXICO BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 186. MEXICO BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 187. MEXICO BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 188. MEXICO BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 189. MEXICO BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. MEXICO BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 191. MEXICO BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 192. MEXICO BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 193. MEXICO BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 194. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. MEXICO BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 198. MEXICO BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 199. MEXICO BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 200. MEXICO BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 214. BRAZIL BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 215. BRAZIL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 217. BRAZIL BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 218. BRAZIL BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 219. BRAZIL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 220. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. BRAZIL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 223. BRAZIL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 224. BRAZIL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 225. BRAZIL BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 226. BRAZIL BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. BRAZIL BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 228. BRAZIL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 229. BRAZIL BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 230. BRAZIL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 233. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 234. ARGENTINA BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 235. ARGENTINA BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 236. ARGENTINA BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 237. ARGENTINA BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 238. ARGENTINA BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 239. ARGENTINA BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 240. ARGENTINA BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 241. ARGENTINA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. ARGENTINA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 243. ARGENTINA BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 244. ARGENTINA BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 245. ARGENTINA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 246. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. ARGENTINA BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 249. ARGENTINA BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 250. ARGENTINA BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 251. ARGENTINA BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 252. ARGENTINA BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. ARGENTINA BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 254. ARGENTINA BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 255. ARGENTINA BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 256. ARGENTINA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 257. ARGENTINA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 258. ARGENTINA BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 290. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 292. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 294. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 296. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 298. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 302. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 304. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 308. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 310. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 312. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 313. GERMANY BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 314. GERMANY BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 315. GERMANY BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 316. GERMANY BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 317. GERMANY BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 318. GERMANY BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 319. GERMANY BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 320. GERMANY BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. GERMANY BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 322. GERMANY BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 323. GERMANY BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 324. GERMANY BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 325. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. GERMANY BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 327. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 328. GERMANY BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 329. GERMANY BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 330. GERMANY BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 331. GERMANY BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. GERMANY BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 333. GERMANY BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 334. GERMANY BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 335. GERMANY BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 336. GERMANY BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 337. GERMANY BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 338. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 339. FRANCE BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 340. FRANCE BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 341. FRANCE BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 342. FRANCE BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 343. FRANCE BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 344. FRANCE BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 345. FRANCE BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 346. FRANCE BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 347. FRANCE BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 348. FRANCE BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 349. FRANCE BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 350. FRANCE BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2030 (USD MILLION)
TABLE 351. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. FRANCE BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 353. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 354. FRANCE BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 355. FRANCE BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 356. FRANCE BIOMARKERS MARKET SIZE, BY RESEARCH USE, 2018-2030 (USD MILLION)
TABLE 357. FRANCE BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 358. FRANCE BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 359. FRANCE BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 360. FRANCE BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 361. FRANCE BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2030 (USD MILLION)
TABLE 362. FRANCE BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 363. FRANCE BIOMARKERS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 364. RUSSIA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 365. RUSSIA BIOMARKERS MARKET SIZE, BY CELLULAR, 2018-2030 (USD MILLION)
TABLE 366. RUSSIA BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2030 (USD MILLION)
TABLE 367. RUSSIA BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2030 (USD MILLION)
TABLE 368. RUSSIA BIOMARKERS MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 369. RUSSIA BIOMARKERS MARKET SIZE, BY GENOMIC, 2018-2030 (USD MILLION)
TABLE 370. RUSSIA BIOMARKERS MARKET SIZE, BY METABOLOMIC, 2018-2030 (USD MILLION)
TABLE 371. RUSSIA BIOMARKERS MARKET SIZE, BY PROTEOMIC, 2018-2030 (USD MILLION)
TABLE 372. RUSSIA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 373. RUSSIA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 374. RUSSIA BIOMARKERS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 375. RUSSIA BIOMARKERS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biomarkers market report include:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 68.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 133.17 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033 - Product Image

Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
Biomarkers - Global Strategic Business Report - Product Image

Biomarkers - Global Strategic Business Report

  • Report
  • 413 Pages
  • Global
From
Genomic Biomarker Market by Product Type, Technology, Application, End User, Biomarker Type - Global Forecast to 2030 - Product Image

Genomic Biomarker Market by Product Type, Technology, Application, End User, Biomarker Type - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Biomarker Testing Services Market by Biomarker Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

Biomarker Testing Services Market by Biomarker Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Next Generation Tissue Biomarkers Market Size, Share & Trends Analysis Report by Product (Reagents & Assays, Instruments & Platforms), Type (Genomic, Proteomic), Technology, Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Next Generation Tissue Biomarkers Market Size, Share & Trends Analysis Report by Product (Reagents & Assays, Instruments & Platforms), Type (Genomic, Proteomic), Technology, Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From

About the Biomarkers Market

Metabolomics biomarkers are a type of biomarker used to measure and analyze the metabolites present in a biological sample. Metabolites are small molecules that are produced as a result of metabolic processes, and they can provide valuable information about the health of an individual. Metabolomics biomarkers are used to identify and quantify metabolites in order to gain insight into the metabolic pathways of an organism. This information can be used to diagnose diseases, monitor the progression of a disease, and evaluate the effectiveness of treatments. Metabolomics biomarkers are used in a variety of fields, including drug discovery, toxicology, nutrition, and personalized medicine. They are also used to identify biomarkers for diseases such as cancer, diabetes, and cardiovascular disease. Companies in the metabolomics biomarker market include Metabolon, Biocrates Life Sciences, Metabolomic Technologies, Metabolon, and Metabolomics Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.